1. Introduction

Regulatory certification for interoperability refers to the legal and technical process through which a regulatory authority verifies that products, technologies, software systems, medical devices, laboratories, databases, or digital infrastructure can exchange information and operate together safely, accurately, and reliably.

Interoperability is particularly important in biotechnology, healthcare, genetic testing, pharmaceutical manufacturing, artificial intelligence, electronic health records, laboratory information systems, and genomic-data management.

Certification ensures that different systems can communicate without compromising:

Data accuracy and integrity.

Patient safety and confidentiality.

Scientific reliability and traceability.

Cybersecurity and information security.

Regulatory compliance.

Cross-border data exchange.

Technical compatibility and continuity of services.

The central legal question is whether a product or system that satisfies its individual technical requirements can also be legally trusted when connected to other regulated systems.

A system may function independently but still create serious risks when connected to another system. Regulatory certification therefore establishes minimum standards for compatibility, safety, accountability, and lawful information exchange.

2. Meaning and Scope of Interoperability Certification

Interoperability certification is a formal assessment confirming that a particular system meets prescribed technical, operational, and legal requirements for interaction with other systems.

It generally involves five dimensions:

Technical interoperability: Systems use compatible interfaces, communication protocols, and technical standards.

Semantic interoperability: Information exchanged between systems has consistent meaning and interpretation.

Organisational interoperability: Institutions have compatible procedures, responsibilities, and governance arrangements.

Legal interoperability: Data exchange and cooperation comply with applicable privacy, confidentiality, intellectual-property, and regulatory requirements.

Security interoperability: Connected systems maintain appropriate authentication, encryption, access controls, and audit mechanisms.

For example, two genetic-testing laboratories may use different analytical platforms. Certification can establish whether their systems exchange genetic results in a standardised format without changing the scientific meaning of the information.

3. Regulatory Framework in Morocco

In Morocco, interoperability certification must be examined through several overlapping legal frameworks rather than assuming that one comprehensive statute governs every form of interoperability.

A. Law No. 84-12 on Medical Devices

Law No. 84-12, concerning medical devices, is particularly relevant to interoperability in biotechnology and healthcare.

Its regulatory structure includes:

Article 5: Essential requirements applicable to medical devices.

Articles 7–11: Regulatory obligations concerning establishments, manufacturing, delegation, and good practices.

Article 12: Prior registration certificate required for placing medical devices on the Moroccan market.

Article 14: Administrative and technical documentation demonstrating performance and conformity.

Article 15: Clinical investigation or evaluation of clinical data to establish performance and safety.

These provisions are important when medical devices must connect with hospital information systems, diagnostic platforms, laboratory equipment, or other medical technologies.

However, registration under this law should not automatically be described as a separate interoperability certificate. The legal question is whether the device satisfies the applicable essential requirements and whether additional technical standards or conditions apply.

sante.gov.ma+2

B. Law No. 11-08 on In Vitro Diagnostic Reagents

This legislation regulates reagents used for in-vitro diagnostic purposes.

It is relevant to interoperability because diagnostic reagents and laboratory technologies must produce reliable and reproducible results.

Interoperability-related regulatory considerations include:

Compatibility between diagnostic equipment and reagents.

Consistency of laboratory reporting formats.

Reliability of diagnostic measurements.

Traceability of samples and test results.

Quality assurance and laboratory documentation.

The implementing framework includes Decree No. 2-12-149 of 25 April 2012.

sante.gov.ma

C. Law No. 09-08 on Personal Data Protection

The exchange of medical, genetic, and biometric information between interoperable systems also raises privacy and data-protection obligations.

Law No. 09-08 is relevant to:

Lawful processing of personal information.

Security and confidentiality of personal data.

Restrictions applicable to sensitive information.

Responsibilities of data controllers.

Conditions governing international transfers of personal data.

Consequently, technical compatibility cannot justify unrestricted access to patient or genetic information.

D. Law No. 06-22 on the National Health System

Morocco's Framework Law No. 06-22 is especially important for healthcare interoperability.

Articles 28 and 29 provide for an integrated national health information system and a shared electronic medical record, subject to applicable personal-data protection legislation.

Articles 30 and 31 establish a healthcare accreditation system based on independent quality assessment and national standards.

These provisions provide a statutory foundation for coordinated health-information infrastructure and institutional quality assurance.

Ma Loi+1

E. Telecommunications Interconnection Regulation

Interoperability also has a significant telecommunications dimension.

Morocco's telecommunications framework, including Law No. 24-96 and the applicable interconnection regulations, gives the National Telecommunications Regulatory Agency (ANRT) an important role in network interconnection.

The regulatory principles include:

Technical compatibility between networks.

Non-discriminatory access.

Network integrity.

Service continuity.

Protection of transmitted information.

Testing of interfaces and interconnection arrangements.

These principles are particularly relevant where biotechnology and healthcare systems rely on telecommunications infrastructure for remote diagnostics, electronic prescriptions, and connected medical devices.

anrt.ma+1

4. Main Requirements for Regulatory Certification

A robust interoperability certification framework should include the following requirements.

4.1 Technical conformity

The applicant should demonstrate that the system complies with recognised technical standards.

Examples include:

HL7 and FHIR for healthcare information exchange.

DICOM for medical imaging.

ISO 13485 for medical-device quality management.

ISO/IEC 27001 for information security management.

ISO/IEC 17025 for testing and calibration laboratories.

These standards are relevant technical references; their mention does not mean that every standard is automatically mandatory under Moroccan law.

4.2 Data accuracy and semantic consistency

A certified system should preserve the meaning of information when transferring it between different platforms.

For example, a genetic-testing laboratory should not convert a genetic variant into an incorrectly interpreted result when transferring information to a hospital database.

4.3 Cybersecurity certification

Regulatory authorities should assess:

Encryption mechanisms.

User authentication.

Access permissions.

Security incident reporting.

System vulnerability management.

Audit trails.

4.4 Clinical and scientific validation

For healthcare and biotechnology applications, interoperability testing should establish that the exchange of information does not affect clinical performance or scientific reliability.

4.5 Independent conformity assessment

Testing should be performed by competent and sufficiently independent assessment bodies.

Certification should identify the system tested, applicable standards, testing conditions, limitations, and validity period.

5. Important Case Laws

The following decisions provide judicial guidance on interoperability, regulatory conformity, technical access, and certification obligations.

Case 1. Microsoft Corp. v Commission (2007)

Important interoperability precedent

Court: Court of First Instance of the European Communities (now General Court).

Case number: T-201/04.

Date: 17 September 2007.

Facts: Microsoft was accused of abusing its dominant market position by refusing to provide competitors with important interoperability information concerning its operating systems.

Legal issue: Whether withholding technical information necessary for interoperability could constitute an abuse of a dominant position.

Decision: The Court substantially upheld the European Commission's findings concerning Microsoft's refusal to provide interoperability information and the associated competition-law infringement.

Legal principle: A dominant technology provider cannot necessarily use control over essential interoperability information to exclude competitors from related markets.

Relevance to certification: Certification requirements should not become instruments through which dominant manufacturers prevent competing technologies from connecting to regulated systems.

EUR-Lex+1

Case 2. SAS Institute Inc. v World Programming Ltd (2012)

Court: Court of Justice of the European Union.

Case number: C-406/10.

Date: 2 May 2012.

Facts: World Programming developed software capable of performing functions similar to SAS software without accessing its source code.

Legal issue: Whether software functionality, programming languages, and data-file formats were protected by copyright.

Decision: The Court held that software functionality, programming languages, and data-file formats used to exploit software functions are not, as such, protected expressions under the relevant computer-program copyright directive.

Legal principle: Technical interoperability and functional compatibility must be distinguished from unlawful reproduction of protected software expression.

Relevance to certification: A regulatory authority should assess whether systems communicate and function correctly without automatically requiring competitors to reproduce proprietary source code.

EUR-Lex+1

Case 3. Medical Devices Registration Dispute – Casablanca Court of Appeal (2022)

Court: Commercial Court of Appeal, Casablanca, Morocco.

Decision number: 5633.

Date: 13 December 2022.

Case number: 2022/8202/3776.

Facts: A dispute arose under an international distribution agreement concerning the documentation needed to register medical devices in Morocco.

The distributor argued that the foreign manufacturer had failed to provide the necessary registration documents.

Legal issue: Which party was responsible for obtaining the medical-device registration certificate under Law No. 84-12?

Decision: The Court held that the obligation to obtain the registration certificate rested with the entity importing and distributing the medical devices in Morocco, under Article 12.

Legal principle: Regulatory obligations must be allocated according to the applicable legislation and the legal status of the responsible economic operator.

Relevance to interoperability: Although this decision does not directly concern interoperability certification, it illustrates why certification and registration responsibilities must be clearly allocated among manufacturers, importers, distributors, and technology operators.

Jurisprudence+1

Case 4. ANRT Interconnection and Access Regulatory Framework

Morocco's telecommunications framework provides an additional regulatory illustration.

The ANRT framework allows regulatory intervention where disagreements arise over network interconnection, access, technical compatibility, and interoperability.

The applicable framework addresses non-discriminatory access, network integrity, interface testing, confidentiality, and service continuity.

This is an important regulatory example, although the cited regulatory provisions should not be mistaken for a judicial judgment.

anrt.ma+2

6. Regulatory Authorities and Their Responsibilities in Morocco

The precise certification authority depends on the product, sector, and applicable legislation. No single institution should be assumed to issue every type of interoperability certificate.

7. Major Legal Challenges

A. Absence of uniform certification requirements

Different industries may apply different technical standards. This creates uncertainty when a product operates across healthcare, biotechnology, telecommunications, and information-technology sectors.

B. Conflict between interoperability and intellectual property

Manufacturers may argue that disclosure of technical interfaces infringes patents, copyright, or trade secrets.

Regulation must balance intellectual-property protection with legitimate interoperability requirements.

C. Cross-border certification recognition

A medical device certified in one jurisdiction may not automatically satisfy Moroccan registration requirements.

Regulators must distinguish foreign conformity assessments from domestic legal authorisation.

D. Data protection conflicts

A technically interoperable system may still violate privacy laws if it transfers personal or genetic data without an appropriate legal basis.

E. Cybersecurity risks

Connecting previously independent systems may create vulnerabilities that were not present during individual product testing.

F. Certification fraud

Manufacturers may provide inaccurate technical documentation or misleading conformity declarations.

Regulatory authorities therefore need inspection, verification, suspension, and enforcement mechanisms.

8. Regulatory Certification Procedure: Recommended Model

A comprehensive certification procedure should follow these stages:

Application

The manufacturer or responsible operator submits technical documentation and identifies the systems with which interoperability is claimed.

Technical assessment

The competent assessment body evaluates interfaces, communication protocols, data formats, and compatibility.

Safety and cybersecurity testing

The system is examined for security vulnerabilities, data integrity, and operational risks.

Clinical or scientific validation

Where relevant, the authority evaluates whether interoperability affects diagnostic accuracy or clinical performance.

Legal conformity assessment

The applicant demonstrates compliance with applicable privacy, medical-device, cybersecurity, and sector-specific requirements.

Certification or regulatory approval

The competent authority or authorised conformity-assessment body issues the appropriate certificate or approval.

Post-certification monitoring

Authorities monitor software updates, system modifications, security incidents, and continuing conformity.

9. Regulatory Reforms Needed in Morocco

Morocco could strengthen interoperability governance through the following measures:

Establish a national interoperability certification framework for regulated digital-health and biotechnology systems.

Develop mandatory technical specifications for high-risk medical and diagnostic applications.

Establish recognised independent interoperability testing laboratories.

Create a national registry of certified interoperable medical technologies.

Introduce periodic reassessment after significant software or hardware modifications.

Establish clear responsibility for manufacturers, importers, distributors, and healthcare institutions.

Develop procedures for mutual recognition of foreign conformity assessments.

Strengthen cybersecurity and personal-data protection requirements.

Provide administrative appeal procedures for rejected, suspended, or withdrawn certifications.

Introduce penalties for fraudulent certification claims and deliberate non-compliance.

A useful institutional development is the Morocco Health Interoperability and Maturity Lab (MOHIM), which describes work on interoperability standards, certification support, and the adoption of IHE standards. Its activities should be distinguished from statutory regulatory approval.

Morocco Health Interoperability & Maturity Lab

10. Conclusion

Regulatory certification for interoperability is an essential component of modern biotechnology, healthcare, and digital infrastructure governance.

In Morocco, Law No. 84-12, Law No. 11-08, Law No. 09-08, Framework Law No. 06-22, and telecommunications legislation provide relevant legal foundations.

The examined judicial decisions demonstrate three important principles:

Interoperability information can have significant competition-law implications.

Functional compatibility must be distinguished from infringement of intellectual-property rights.

Regulatory certification responsibilities must be allocated according to applicable statutory obligations.

However, the cited Moroccan medical-device judgment concerns registration responsibility rather than interoperability certification itself. A comprehensive Moroccan judicial doctrine specifically addressing interoperability certification remains to be established through further case law.

Ultimately, the objective should be to ensure that different regulated technologies can communicate safely and reliably without compromising patient rights, scientific accuracy, cybersecurity, or fair competition.

11. Key Legal References

Research note: The European judgments are comparative authorities, not binding precedents in Morocco. Their principles can nevertheless inform comparative analysis of Moroccan regulatory reform.